Read + Share
Yurdaydin C, Keskin O, Yurdcu E, Caliskan A, et al. A Phase ii dose finding study of lonafarnib and ritonavir with or without
interferon alpha for chronic delta hepatitis. Hepatology 2021 Dec 3. doi: 10.1002/hep.32259.
PMID: 34860418
|
 |
|
Yurdaydin C, Keskin O, Yurdcu E, Caliskan A, et al. A Phase ii dose finding study of lonafarnib and ritonavir with or without
interferon alpha for chronic delta hepatitis. Hepatology 2021 Dec 3. doi: 10.1002/hep.32259.
PMID: 34860418
|
|
|
|